Show simple item record

dc.contributor.authorMaher, Geoffrey J
dc.contributor.authorRalph, Hannah K
dc.contributor.authorDing, Zhihao
dc.contributor.authorKoelling, Nils
dc.contributor.authorMlcochova, Hana
dc.contributor.authorGiannoulatou, Eleni
dc.contributor.authorDhami, Pawan
dc.contributor.authorPaul, Dirk S
dc.contributor.authorStricker, Stefan H
dc.contributor.authorBeck, Stephan
dc.contributor.authorMcVean, Gilean
dc.contributor.authorWilkie, Andrew OM
dc.contributor.authorGoriely, Anne
dc.date.accessioned2018-12-12T00:31:00Z
dc.date.available2018-12-12T00:31:00Z
dc.date.issued2018-12
dc.identifier.issn1088-9051
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/286700
dc.description.abstractMosaic mutations present in the germline have important implications for reproductive risk and disease transmission. We previously demonstrated a phenomenon occurring in the male germline, whereby specific mutations arising spontaneously in stem cells (spermatogonia) lead to clonal expansion, resulting in elevated mutation levels in sperm over time. This process, termed "selfish spermatogonial selection," explains the high spontaneous birth prevalence and strong paternal age-effect of disorders such as achondroplasia and Apert, Noonan and Costello syndromes, with direct experimental evidence currently available for specific positions of six genes (FGFR2, FGFR3, RET, PTPN11, HRAS, and KRAS). We present a discovery screen to identify novel mutations and genes showing evidence of positive selection in the male germline, by performing massively parallel simplex PCR using RainDance technology to interrogate mutational hotspots in 67 genes (51.5 kb in total) in 276 biopsies of testes from five men (median age, 83 yr). Following ultradeep sequencing (about 16,000×), development of a low-frequency variant prioritization strategy, and targeted validation, we identified 61 distinct variants present at frequencies as low as 0.06%, including 54 variants not previously directly associated with selfish selection. The majority (80%) of variants identified have previously been implicated in developmental disorders and/or oncogenesis and include mutations in six newly associated genes (BRAF, CBL, MAP2K1, MAP2K2, RAF1, and SOS1), all of which encode components of the RAS-MAPK pathway and activate signaling. Our findings extend the link between mutations dysregulating the RAS-MAPK pathway and selfish selection, and show that the aging male germline is a repository for such deleterious mutations.
dc.description.sponsorshipWe thank the UCL Cancer Institute Genomics and Genome Engineering Core Facility (supported by the Cancer Research UK – UCL Centre), for providing access to the RainDance Thunderstorm platform, which was purchased on a Wellcome multi-user grant (99148). This work was primarily supported by grants from the Wellcome (grant 091182 to A.G., G.McV. and A.O.M.W.; grant 102731 to A.O.M.W. and studentship 105361 to H.K.R.), the Simons Foundation (332759 to A.G.) and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme (to A.G.). S.B., P.D. and S.H.S. were supported by a Wellcome programme grant and D.S.P. was supported by EU-FP7. We acknowledge funding from the Medical Research Council (MRC) through the WIMM Strategic Alliance (G0902418 and MC_UU_12025) and the support of the High-Throughput Genomics core facility by the Wellcome grant 090532.
dc.format.mediumPrint-Electronic
dc.languageeng
dc.publisherCold Spring Harbor Laboratory
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectTestis
dc.subjectHumans
dc.subjectras Proteins
dc.subjectMitogen-Activated Protein Kinases
dc.subjectSignal Transduction
dc.subjectMutation
dc.subjectAged
dc.subjectAged, 80 and over
dc.subjectMiddle Aged
dc.subjectMale
dc.subjectGenetic Variation
dc.titleSelfish mutations dysregulating RAS-MAPK signaling are pervasive in aged human testes.
dc.typeArticle
prism.endingPage1790
prism.issueIdentifier12
prism.publicationDate2018
prism.publicationNameGenome Res
prism.startingPage1779
prism.volume28
dc.identifier.doi10.17863/CAM.34007
dcterms.dateAccepted2018-10-20
rioxxterms.versionofrecord10.1101/gr.239186.118
rioxxterms.versionVoR
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.licenseref.startdate2018-12
dc.contributor.orcidMcVean, Gilean [0000-0002-5012-4162]
dc.contributor.orcidWilkie, Andrew OM [0000-0002-2972-5481]
dc.contributor.orcidGoriely, Anne [0000-0001-9229-7216]
dc.identifier.eissn1549-5469
rioxxterms.typeJournal Article/Review
pubs.funder-project-idMedical Research Council (MR/L003120/1)
pubs.funder-project-idEuropean Commission (282510)
pubs.funder-project-idBritish Heart Foundation (None)
cam.issuedOnline2018-10-24


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 International
Except where otherwise noted, this item's licence is described as Attribution 4.0 International